Cargando…
Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
The purpose of this narrative review is to provide a summary of the clinical trials on the efficacy and safety of clascoterone 1% cream (Winlevi) to grant providers an understanding of which patients will benefit most from this novel topical antiandrogen medication. Clascoterone 1% cream (Winlevi) o...
Autores principales: | Sanchez, Carol, Keri, Jonette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297041/ https://www.ncbi.nlm.nih.gov/pubmed/35874458 http://dx.doi.org/10.2147/CCID.S289750 |
Ejemplares similares
-
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
por: Hebert, Adelaide, et al.
Publicado: (2020) -
An update on the management of acne vulgaris
por: Keri, Jonette, et al.
Publicado: (2009) -
Use of topical clascoterone for the treatment of hidradenitis suppurativa
por: Cunningham, Kaitlynne N., et al.
Publicado: (2023) -
Psychosocial impact of acne and postinflammatory
hyperpigmentation
por: França, Katlein, et al.
Publicado: (2017) -
Chemical peels in the treatment of acne: patient selection and perspectives
por: Castillo, David E, et al.
Publicado: (2018)